Updates are available Correction dated 2022-06-02

Article History

Received: 31 October 2021

Accepted: 23 January 2022

First Online: 7 February 2022

Change Date: 2 June 2022

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s00432-022-04077-z

Declarations

:

: Dr. Horinouchi received research grants from MSD K.K., Chugai Pharmaceutical Co., Ltd., Genomic Health, Inc., Ono Pharmaceutical Co. Ltd, Bristol-Myers Squibb, Daiichi Sankyo Company, Limited, AstraZeneca K.K, AbbVie GK, and received honoraria from Eli Lilly Japan K.K., AstraZeneca K.K, Taiho Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., MSD K.K., Novartis Pharma K.K., Takeda Pharmaceutical Co. Ltd., Kyowa Kirin Co., Ltd., Bristol-Myers Squibb. Dr. Yonemori had advisory roles of Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co. Ltd., and received honoraria from Takeda Pharmaceutical Co. Ltd., AstraZeneca K.K, Pfizer Inc., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K. Dr. Okusaka's advisory roles were Taiho Pharmaceutical Co., Ltd., Daiichi Sankyo Company, Limited, Sumitomo Dainippon Pharma Co., Ltd., Bristol-Myers Squibb, AstraZeneca K.K., Eisai Co., Ltd., Nihon Servier. In addition, Dr.Okusaka received honoraria from ElmediX, Meiji Seika Pharma Co., Ltd., MSD K.K., AstraZeneca K.K, AbbVie GK, Eisai Co., Ltd., Ono Pharmaceutical Co. Ltd, Yakult Honsha Co.,Ltd., Shire plc, Daiichi Sankyo Company, Limited, Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co. Ltd., Chugai Pharmaceutical Co., Ltd., Teijin Pharma Limited., Eli Lilly Japan K.K., Nippon Shinyaku Co., Ltd., Nihon Servier, Novartis Pharma K.K., Bayer Yakuhin, Ltd., Pfizer Inc., Mundipharma K.K., and received research grants from AstraZeneca K.K., Eisai Co., Ltd., Bristol-Myers Squibb, MSD K.K., Sumitomo Dainippon Pharma Co., Ltd. Dr. Boku received honoraria for lecture fees from Ono Pharmaceutical Co. Ltd., and Taiho Pharmaceutical Co., Ltd., and a research grant from Ono Pharmaceutical Co. Ltd. and Takeda Pharmaceutical Co. Ltd. Dr.Yamazaki reports personal fees and non-financial support from Ono Pharmaceutical Co. Ltd., Bristol-Myers Squibb, Novartis Pharma K.K., MSD K.K., individual fees from Merck Serono Co., Ltd., Takeda Pharmaceutical Co. Ltd., Chugai Pharmaceutical Co., Ltd. Dr. Kawai has received honoraria for lecture fees from Taiho Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Eisai Co., Ltd., <i>Takara Bio</i> Inc., Daiichi Sankyo, Bayer Yakuhin, Ltd., Kyowa Kirin Co., Ltd., Novartis Pharma K.K., and research expenses from Taiho Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Eisai Co., Ltd., Takara Bio Inc., and Daiichi Sankyo Company, Limited. Dr. Ohe had the advisory role of AstraZeneca K.K., Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co. Ltd., Bristol-Myers Squibb, Kyorin Pharmaceutical Co., Ltd., <i>Celltrion</i> Pharm Inc., Amgen Inc., and Nippon Kayaku Co., Ltd. In addition, Dr.Ohe received personal fees from AstraZeneca K.K., Chugai Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Ono Pharmaceutical Co. Ltd, Bristol-Myers Squibb, Boehringer Ingelheim, Bayer Yakuhin, Ltd., Pfizer Inc., MSD K.K., T Taiho Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Kyowa Hakko Kirin Co., Ltd., and received research grants from AstraZeneca K.K., Chugai Pharmaceutical Co., Ltd., Lilly, Ono Pharmaceutical Co. Ltd, Bristol-Myers Squibb, Kyorin Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Pfizer Inc., Taiho Pharmaceutical Co., Ltd., Novartis K.K, Ignyta Inc., Takeda Pharmaceutical Co. Ltd., Kissei Pharmaceutical Co., Ltd., Daiichi Sankyo Company, Limited, Janssen Pharmaceutical K.K., Loxo Oncology. Dr. Kusumoto received honoraria for lecture fees from AstraZeneca K.K. and Daiichi Sankyo Company, Limited, and research grants from Canon medical systems corporation. The remaining authors declare no conflict of interest.

: The Ethics Review Committee of the National Cancer Center Central Hospital approved this study protocol (Approval number: 2019-069).

: This manuscript contains no individual data.